Differential expression of interferon-induced microRNAs in patients with chronic hepatitis C virus infection treated with pegylated interferon alpha

Differential expression of interferon-induced microRNAs in patients with chronic hepatitis C virus infection treated with pegylated interferon alpha

<p>Abstract</p> <p>There have been reports of in-vitro interferon (IFN)-mediated antiviral activity against the hepatitis C virus (HCV) through microRNAs (miRNAs). The main aim of this study was to evaluate the expression of several miRNAs (miR-1, miR-30, miR-128, miR-196, miR-296)...

Full description

Bibliographic Details
Main Authors:	Riva Elisabetta, Taliani Gloria, Racciatti Delia, Selvaggi Carla, Vecchiet Jacopo, Zingariello Pompea, Scagnolari Carolina, Pizzigallo Eligio, Antonelli Guido
Format:	Article
Language:	English
Published:	BMC 2010-11-01
Series:	Virology Journal
Online Access:	http://www.virologyj.com/content/7/1/311

Similar Items

Evaluation of the Results of Patients Treated By Pegylated Interferon Alpha Therapy
by: Çiğdem PAPİLA, et al.
Published: (2015-09-01)

Effect of Pegylated Interferon on Non-Responders and Relapsers with Interferon
by: Hisham O. Akbar, et al.
Published: (2002-04-01)

[Pegylation and interferons in multiple sclerosis]
by: Diego Centonze, et al.
Published: (2016-07-01)

Pegylated Interferons and Their Use in Clinical Practice
by: Alpay AZAP, et al.
Published: (2003-12-01)

Pegylated interferon-alpha-2a for the treatment of ocular surface squamous neoplasia
by: Murtuza Nuruddin, et al.
Published: (2022-01-01)

Pegylated-interferon alpha therapy for treatment-experienced chronic hepatitis B patients.
by: Ming-Lun Yeh, et al.
Published: (2015-01-01)

Long-term pegylated interferon-&alpha; and its potential in the treatment of melanoma
by: Reinhard Dummer, et al.
Published: (2009-04-01)

Non-pegylated and Pegylated Interferon Alpha-2a in Cutaneous T-cell Lymphoma and the Risk of Severe Ocular Side-effects
by: Jana D. Albrecht, et al.
Published: (2022-05-01)

Thyrotoxicosis with pegylated interferon alfa-2b.
by: Lowndes, SA, et al.
Published: (2010)

Microalbuminuria and pegylated interferon in hepatitis-C patients
by: Yasser Elshahawi, et al.
Published: (2015-01-01)

Interferon-lambda 3 and 4 Polymorphisms Increase Sustained Virological Responses and Regulate Innate Immunity in Antiviral Therapy With Pegylated Interferon-Alpha
by: Andréa Marques Vieira da Silva, et al.
Published: (2021-07-01)

The interferon lambda 4 rs368234815 predicts treatment response to pegylated-interferon alpha and ribavirin in hemophilic patients with chronic hepatitis C
by: Maryam Keshvari, et al.
Published: (2016-01-01)

Comparison of pegylated interferon monotherapy and de novo pegylated interferon plus tenofovir combination therapy in patients with chronic hepatitis B
by: Zheng C, et al.
Published: (2019-04-01)

Pegylated-interferon-alpha treatment modulating the immune response of cytotoxic lymphocytes in cervical intraepithelial neoplasia
by: Letícia Montes Stark, et al.
Published: (2021-06-01)

Acute pericarditis due to pegylated interferon alpha therapy for chronic HCV hepatitis - Case report
by: Gliga Smaranda, et al.
Published: (2011-03-01)

A Case of Chronic Neutrophilic Leukemia Successfully Treated with Pegylated Interferon Alpha-2a
by: Mohamed A. Yassin, et al.
Published: (2015-01-01)

A Case of Chronic Neutrophilic Leukemia Successfully Treated with Pegylated Interferon Alpha-2a
by: Mohamed A. Yassin, et al.
Published: (2015-04-01)

Thyroid disturbances in children treated with combined pegylated interferon-alpha and ribavirin for chronic hepatitis C
by: Yasser K. Rashed, et al.
Published: (2020-02-01)

Novel Pegylated Interferon for the Treatment of Chronic Viral Hepatitis
by: Yi-Wen Huang, et al.
Published: (2022-05-01)

[Pegylated interferon beta-1a on the Italian market]
by: Mario Eandi
Published: (2016-07-01)

Use of Pegylated Interferon Alpha-2a in Cutaneous T-cell Lymphoma: A Retrospective Case Collection
by: Janika Gosmann, et al.
Published: (2023-10-01)

Analysis of clinical characteristics of thyroid disorders in patients with chronic hepatitis B treated with pegylated-interferon alpha
by: Yisi Liu, et al.
Published: (2023-05-01)

Repeated Panniculitis Induced by Pegylated Interferon Alpha 2a in a Patient with Chronic Hepatitis C
by: June Seok Song, et al.
Published: (2016-05-01)

The effects of pegylated interferon alpha 2b on bile-duct ligation induced liver fibrosis in rats
by: Billur Canbakan, et al.
Published: (2009-07-01)

USE OF HEMATOPOIETIC GROWTH FACTOR IN THE MANAGEMENT OF HEMATOLOGICAL SIDE EFFECTS ASSOCIATED TO ANTIVIRAL TREATMENT FOR HCV HEPATITIS
by: Paola Mancino, et al.
Published: (2010-03-01)

USE OF HEMATOPOIETIC GROWTH FACTOR IN THE MANAGEMENT OF HEMATOLOGICAL SIDE EFFECTS ASSOCIATED TO ANTIVIRAL TREATMENT FOR HCV HEPATITIS
by: Claudio Ucciferri, et al.
Published: (2010-02-01)

A Case Report of a New Inflammatory Eye Syndrome in an Hiv Positive Patient: The Immune Restoration Uveitis
by: M. Dalessandro, et al.
Published: (2005-01-01)

Extensive psoriasis induced by pegylated interferon: a case report
by: Citro Vincenzo, et al.
Published: (2007-09-01)

Response predictors to treatment with pegylated interferon in chronic hepatitis B
by: Paulo Roberto Abrão Ferreira, et al.

Can pegylated interferon improve the outcome of polycythemia vera patients?
by: Elena Crisà, et al.
Published: (2017-01-01)

Response predictors to treatment with pegylated interferon in chronic hepatitis B
by: Paulo Roberto Abrão Ferreira, et al.
Published: (2010-09-01)

Individualized treatment of chronic hepatitis C with pegylated interferon and ribavirin
by: Roberto J Carvalho-Filho, et al.
Published: (2010-03-01)

Therapeutic effectiveness of biosimilar standard interferon versus pegylated interferon for chronic hepatitis C genotypes 2 or 3
by: Aline Gonzalez Vigani, et al.
Published: (2012-05-01)

Therapeutic effectiveness of biosimilar standard interferon versus pegylated interferon for chronic hepatitis C genotypes 2 or 3
by: Aline Gonzalez Vigani, et al.

Regression of alveolar echinococcosis after chronic viral hepatitis C treatment with pegylated interferon alpha 2a
by: Dražilová S., et al.
Published: (2012-09-01)

Outcome of Pregnancy in the Era of Pegylated Interferon Alpha 2a in Females with Essential Thrombocythemia: An Experience from Qatar
by: Mohammad Abu-Tineh, et al.
Published: (2020-03-01)

Adefovir dipivoxil and pegylated interferon alpha for the treatment of chronic hepatitis B: an updated systematic review and economic evaluation
by: J Jones, et al.
Published: (2009-07-01)

Safety and efficacy of treatment with pegylated interferon alpha-2a with ribavirin in chronic hepatitis C genotype 4
by: Juan José Urquijo, et al.
Published: (2013-01-01)

Schwannoma response to interferon alpha
by: Jennifer Novak, et al.
Published: (2017-12-01)

Successful treatment of HCV/HBV/HDV-coinfection with pegylated interferon and ribavirin
by: Janine Hartl, et al.
Published: (2012-07-01)